|
|
 Safety Information - November 23, 2008
| In an unprecedented display of public animosity at the Food and Drug Administration, one of its top employees resigns Wednesday to protest the agency's refusal to allow over-the-counter sales of emergency contraception. Assistant Commissioner Susan Wood charges that FDA's leader overruled his own scientists' determination that the morning-after pill could safely be sold without a prescription, and stunned his employees last week by postponing indefinitely a decision on whether to let that happen, The Associated Press reports | | The U.S Food & Drug Administration (FDA) issues a favorable response to a petition filed by health company Nutrition 21, recognizing chromium picolinate as a safe nutritional supplement that may reduce the risk of insulin resistance and possibly type two diabetes | | A trial study is currently underway from Romark Laboratories to help victims of the vicious Chron's Disease. Romark Laboratories has begun enrolling patients in a clinical trial evaluating Alinia (nitazoxanide) for treatment of mild to moderate active Crohn's disease in adults | | A trial study is currently underway from Romark Laboratories to help victims of the vicious Chron's Disease. Romark Laboratories has begun enrolling patients in a clinical trial evaluating Alinia (nitazoxanide) for treatment of mild to moderate active Crohn's disease in adults | | A new study shows that men who take Viagra to overcome erectile dysfunction are not at greater risk of having a heart attack in the short-term. The finding is "consistent with the growing body of evidence" demonstrating the cardiovascular safety of Viagra, Dr. Murray A. Mittleman from Harvard Medical School in Boston and colleagues note in the American Journal of Cardiology | |
|
|